Bone Marrow TransplantationTransplantation, AutologousBone MarrowBone Marrow CellsBone Marrow PurgingTransplantation, HomologousWhole-Body IrradiationCombined Modality TherapyCyclophosphamideCarmustineLymphoma, Non-HodgkinBone and BonesHematopoietic Stem CellsGraft vs Host DiseaseMelphalanHematopoietic Stem Cell TransplantationColony-Forming Units AssayAntineoplastic Combined Chemotherapy ProtocolsBusulfanRemission InductionBone Marrow DiseasesTransplantation ConditioningLeukemiaEtoposideHematopoiesisLeukemia, Myeloid, AcuteHodgkin DiseaseCytarabineRecurrenceLeukemia, MyeloidGraft SurvivalTreatment OutcomeAnemia, AplasticPrecursor Cell Lymphoblastic Leukemia-LymphomaActuarial AnalysisTransplantation ChimeraVincristineTime FactorsPodophyllotoxinBone Marrow ExaminationSurvival AnalysisBone RemodelingMice, Inbred C57BLLymphomaRadiation ChimeraDrug EvaluationGranulocytesBone Marrow NeoplasmsTissue DonorsTransplantation, IsogeneicLeukocyte CountSalvage TherapyGranulocyte Colony-Stimulating FactorLiver TransplantationAcute DiseaseThiotepaStem Cell TransplantationMyelodysplastic SyndromesDisease-Free SurvivalHistocompatibility TestingGranulocyte-Macrophage Colony-Stimulating FactorCell DifferentiationSurvival RateFollow-Up StudiesMultiple MyelomaHistocompatibilityT-LymphocytesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBlood Cell CountCells, CulturedCell SeparationBone DensityAntibodies, MonoclonalImmunosuppressionAntigens, CD34Bone ResorptionPlatelet CountPrognosisLymphatic IrradiationPrednisoneMitoxantroneRetrospective StudiesFlow CytometryNeuroblastomaHematologic DiseasesDoxorubicinHepatic Veno-Occlusive DiseaseImmunosuppressive AgentsSpleenColony-Stimulating FactorsKidney TransplantationBone TransplantationMesnaRecombinant ProteinsCyclosporineNeutropeniaProspective StudiesGonadal DisordersOvarian Function TestsRicin